Merck & Co. Inc. (MRK)

$ 115.68
   
  • Change Today:
    $1.50
  • 52 Week High: $122.46
  • 52 Week Low: $73.47
  • Currency: US Dollars
  • Shares Issued: 2,474.63m
  • Volume: 9,092,520
  • Market Cap: $286,265m
  • RiskGrade: 92

Latest ShareCast News

Merck & Co to spin off cancer unit ahead of Keytruda patent cliff

By Benjamin Chiou

Date: Monday 23 Feb 2026

(Sharecast News) - US pharma group Merck & Co is set to spin off its oncology operations in an effort to keep its wider healthcare businesses immune from a forthcoming patent cliff for its blockbuster Keytruda drug.

Merck News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Merck Market Data

Currency US Dollars
Share Price $ 115.68
Change Today $ 1.50
% Change 1.31 %
52 Week High $122.46
52 Week Low $73.47
Volume 9,092,520
Shares Issued 2,474.63m
Market Cap $286,265m
RiskGrade 92

What The Brokers Say

Strong Buy 8
Buy 10
Neutral 10
Sell 0
Strong Sell 0
Total 28
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 23-Mar-2026

Time Volume / Share Price
16:02 1,332,226 @ $115.68
16:00 142 @ $115.69
16:00 300 @ $115.68
16:00 200 @ $115.68
15:59 200 @ $115.68

Top of Page